Zealand Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Zealand Pharma has a total shareholder equity of DKK1.6B and total debt of DKK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are DKK2.0B and DKK387.2M respectively.
Key information
0%
Debt to equity ratio
kr.0
Debt
Interest coverage ratio | n/a |
Cash | kr.1.63b |
Equity | kr.1.59b |
Total liabilities | kr.387.15m |
Total assets | kr.1.98b |
Recent financial health updates
Auditors Are Concerned About Zealand Pharma (CPH:ZEAL)
Mar 17Here's Why We're Watching Zealand Pharma's (CPH:ZEAL) Cash Burn Situation
Oct 03Recent updates
Auditors Are Concerned About Zealand Pharma (CPH:ZEAL)
Mar 17Here's Why We're Watching Zealand Pharma's (CPH:ZEAL) Cash Burn Situation
Oct 03Downgrade: Here's How Analysts See Zealand Pharma A/S (CPH:ZEAL) Performing In The Near Term
Aug 14Some Zealand Pharma A/S (CPH:ZEAL) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 14Is Zealand Pharma's (CPH:ZEAL) 113% Share Price Increase Well Justified?
Mar 11What You Need To Know About Zealand Pharma A/S' (CPH:ZEAL) Investor Composition
Jan 12Financial Position Analysis
Short Term Liabilities: ZEAL's short term assets (DKK1.8B) exceed its short term liabilities (DKK284.6M).
Long Term Liabilities: ZEAL's short term assets (DKK1.8B) exceed its long term liabilities (DKK102.6M).
Debt to Equity History and Analysis
Debt Level: ZEAL is debt free.
Reducing Debt: ZEAL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ZEAL has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ZEAL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.